News Results 1-10 of 318

Sponsored Links

Fewer Seizures.

More Control. Keppra. Sign Up to Receive the Latest News.

www.Keppra.com

Regence sets a high bar

News  |  www.bizjournals.com | 12 hours 30 minutes ago

I must correct a misstatement on Regence’s position regarding coverage of Lyrica in a recent article (“Doctors protest Regence’s stance on fibromyalgia,” Sept. 12). Medications from at least three different classes have relieved fibromyalgia symptoms for decades.

http://www.bizjournals.com/portland/stories/2008/10/13/editorial5.html?ana=from_rss

Court Papers Link Pfizer to Bid to Quash Neurontin Study

News  |  health.einnews.com | Oct 10, 2008

EIN News is a leading online news monitoring service which has served millions of readers around the world since 1995. We invite you to join a community of professionals from private industry, institutions, and governments that rely on EIN News as a critical source for research and breaking news.

http://health.einnews.com/users/splash_login.php?redir=%2Fnews.php%3Fnid%3D555328

AstraZeneca's Purplepill.com Tops the List of Most Visited Pharmaceutical Brand Web Sites in Q2 2008

Press Release  |  www.prnewswire.com | Oct 9, 2008

Ramped Up Marketing Efforts and FDA Activity Drive Growth at Top Brand.com Sites RESTON, Va., Oct. 9 /PRNewswire-FirstCall/ -- comScore, Inc. (Nasdaq: SCOR), a leader in measuring the digital world, today released a study of the top pharmaceutical brand Web sites in Q2 2008.

http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=109&STORY=/www/story/10-09-2008/0004901269&EDATE=

Experts Conclude Pfizer Inc. Manipulated Studies

News  |  www.biospace.com | Oct 8, 2008

New York Times -- The drug maker Pfizer earlier this decade manipulated the publication of scientific studies to bolster the use of its epilepsy drug Neurontin for other disorders, while suppressing research that did not support those uses, according to experts who reviewed thousands of company

http://www.biospace.com/news_story.aspx?StoryID=112251&full=1

Lawsuit claims Pfizer massaged Neurontin studies

News  |  uk.reuters.com | Oct 8, 2008

LONDON (Reuters) - Pfizer Inc tried to suppress medical studies that did not support the use of its epilepsy drug Neurontin, internal Pfizer documents submitted in a U.S. lawsuit against the company showed. The

http://uk.reuters.com/article/healthNews/idUKTRE49746M20081008?feedType=RSS&feedName=healthNews

Lawsuit claims Pfizer massaged Neurontin studies (Reuters)

News  |  biz.yahoo.com | Oct 8, 2008

Lawsuit claims Pfizer massaged Neurontin studies. - LONDON (Reuters) - Pfizer Inc (NYSE:PFE - News) tried to suppress medical studies that did not support the use of its epilepsy drug Neurontin, internal Pfizer documents submitted in a U.S. lawsuit against the company showed.

http://biz.yahoo.com/rb/081008/business_us_pfizer.html?.v=1

A Tale of Three Pharmaceuticals: Abbott Labs, Pfizer and Eli Lilly & Co. (at Seeking Alpha)

News  |  seekingalpha.com | Sep 23, 2008

Investors have long enjoyed a love-hate relationship with pharmaceutical stocks. This sector is unique in that their products are effectively scheduled for obsolescence via expiring patents.

http://seekingalpha.com/article/96929-a-tale-of-three-pharmaceuticals-abbott-labs-pfizer-and-eli-lilly-co?source=yahoo

Depomed starts late-stage test of hot flash drug (at bizjournals.com)

News  |  sanfrancisco.bizjournals.com | Sep 17, 2008

This will be the first of two Phase III trials for the drug, Gabapentin GR. It’s a new formulation of an already approved drug that’s used to treat pain following shingles or seizures. Each trial will involve about 540 women.

http://sanfrancisco.bizjournals.com/sanfrancisco/stories/2008/09/15/daily41.html?ana=yfcpc

Pfizer to Bring Back Chantix Ads (at The Wall Street Journal Online)

News  |  us.rd.yahoo.com | Sep 12, 2008

Amid concerns about side effects, the company earlier this year stopped running ads that mentioned the smoking-cessation drug by name. That's set to change Sunday, when a new campaign appears on TV.

http://us.rd.yahoo.com/finance/external/xbwsj/rss/SIG=12alk3l12/*http://blogs.wsj.com/health/2008/09/12/pfizer-to-bring-back-chantix-ads/?mod=yahoo_hs

Rituximab prescribing info revised to reflect risk of progressive multifocal leukoencephalopathy.

News  |  www.fda.gov | Sep 11, 2008

symbol indicates an Adobe Acrobat file. To read this format, use the free Acrobat Reader software. Select the "Get Acrobat" button to open the Adobe Acrobat download site in a new window browser window.

http://www.fda.gov/medwatch/safety/2008/safety08.htm#Rituxan

Results 1-10 of 318

Want to put this widget on your blog or personal homepage? Choose your site from the list below.
Add to Google
Or copy the embed script code below and paste it on your website:
Embed code:
>

Refine by Content Type:

  • Refined by: News  

Refine by Source:

61 Sources ...